IP Library Assignment 052095/0262
Patent Assignment
Reel/Frame 052095/0262

Security Interest

Recorded: 2020-03-12 Pages: 7
Assignor
COVIS PHARMA B.V.
Executed: 2020-03-10
Assignee
CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
77 W. WACKER DRIVE, 10TH FLOOR, CHICAGO, ILLINOIS, 60661
Covered Properties (27)
Combination of riluzole and of gabapentin and its use as a medicament
Patent: 6,350,768 →
Application: 09/718,543 →
Riluzole and Alpha-Tocopherol Combination
Patent: 6,642,262 →
Application: 09/854,318 →
Publication: US 2002/0019426
Ciclesonide Contained Pharmaceutical Composition for Application to Mucosa
Patent: 6,767,901 →
Application: 10/110,629 →
Ciclesonide Containing Aqueous Pharmaceutical Composition
Patent: 8,383,611 →
Application: 10/110,632 →
Process for the Production of 16,17-[{Cyclohexylmethylen)Bis(Oxy)]-11,21-Dihydroxy-Pregna-1,4-Dien-3,20-Dion or Its 21-Isobutyrat by Transketalisation
Patent: 7,468,433 →
Application: 10/399,689 →
Publication: US 2005/0080063
Ciclesonide-Containing Sterile Aqueous Suspension
Patent: 8,182,824 →
Application: 10/519,484 →
Publication: US 2006/0166953
Use of the Combination of Ciclesonide and Antihistamines for the Treatment of Allergic Rhinitis
Patent: 7,879,832 →
Application: 10/524,821 →
Publication: US 2005/0245493
Combination Medicament
Patent: 7,879,833 →
Application: 10/537,356 →
Publication: US 2006/0025392
Process for preparing crystalline ciclesonide with defined particle size
Patent: 9,422,327 →
Application: 10/549,631 →
Publication: US 2006/0128954
Formoterol and Ciclesonide Combination
Patent: 8,435,497 →
Application: 10/559,383 →
Publication: US 2006/0127323
Use of Ciclesonide for the Treatment of Respiratory Diseases
Patent: 8,371,292 →
Application: 10/571,311 →
Publication: US 2007/0025923
Compliance monitor and method
Patent: 8,464,707 →
Application: 10/572,316 →
Publication: US 2007/0023034
Stabilized Pharmaceutical Product
Patent: 7,736,673 →
Application: 11/259,495 →
Publication: US 2006/0147537
Stable Pharmaceutical Products
Patent: 7,947,744 →
Application: 11/325,875 →
Publication: US 2006/0104917
Ciclesonide containing sterile aqueous suspension
Patent: 8,481,516 →
Application: 12/448,351 →
Publication: US 2010/0009951
Ciclesonide-Containing Sterile Aqueous Suspension
Patent: 8,268,240 →
Application: 12/461,647 →
Publication: US 2010/0034696
Stabilized Pharmaceutical Product
Patent: 8,029,811 →
Application: 12/771,557 →
Publication: US 2010/0247585
Stable Pharmaceutical Products
Patent: 8,288,445 →
Application: 12/951,608 →
Publication: US 2011/0064814
Combination Medicament
Patent: 8,258,124 →
Application: 12/973,350 →
Publication: US 2011/0086827
Use of the Combination of Ciclesonide and Antihistamines for the Treatment of Allergic Rhinitis
Patent: 8,486,923 →
Application: 12/973,414 →
Publication: US 2011/0092471
Stabilized Pharmaceutical Product
Patent: 8,163,299 →
Application: 13/219,046 →
Publication: US 2011/0308975
Stabilized Pharmaceutical Product
Patent: 8,440,210 →
Application: 13/437,569 →
Publication: US 2012/0247982
Ciclesonide Containing Aqueous Pharmaceutical Composition
Application: 13/688,659 →
Publication: US 2013/0095146
Pharmaceutical Aerosol Product for Administration by Oral or Nasal Inhalation
Application: 14/238,055 →
Publication: US 2014/0170081
Aqueous Suspensions of Ciclesonide for Nebulisation
Application: 14/865,637 →
Publication: US 2016/0015634
Use of Ciclesonide for the Treatment of Respiratory Diseases
Application: 16/440,557 →
Publication: US 2019/0290661
Metered Dose Inhaler
Patent: 582,544 →
Application: 29/283,277 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name Sep 4, 2007
From: ALTANA PHARMA AG
To: NYCOMED GMBH
Reel/Frame 019781/0225 →
Change of Name Sep 4, 2007
From: ALTANA PHARMA AG
To: NYCOMED GMBH
Reel/Frame 019783/0625 →
Change of Name Mar 26, 2013
From: NYCOMED GMBH
To: TAKEDA GMBH
Reel/Frame 030091/0737 →
Release of Patent Security Interest Apr 21, 2015
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: COVIS PHARMA S.A.R.L.; COVIS PHARMA HOLDINGS S.A.R. L.
Reel/Frame 035475/0336 →
Merger Jul 28, 2015
From: TAKEDA GMBH
To: NYCOMED ASSET MANAGEMENT GMBH
Reel/Frame 036193/0178 →
Merger Jul 28, 2015
From: NYCOMED ASSET MANAGEMENT GMBH
To: NYCOMED GERMANY HOLDING GMBH
Reel/Frame 036201/0261 →
Merger Jul 28, 2015
From: NYCOMED ASSET MANAGEMENT GMBH
To: NYCOMED GERMANY HOLDING GMBH
Reel/Frame 036201/0478 →
Merger Jul 28, 2015
From: TAKEDA GMBH
To: NYCOMED ASSET MANAGEMENT GMBH
Reel/Frame 036193/0224 →
Change of Name Jul 29, 2015
From: NYCOMED GERMANY HOLDING GMBH
To: TAKEDA GMBH
Reel/Frame 036205/0192 →
Change of Name Jul 29, 2015
From: NYCOMED GERMANY HOLDING GMBH
To: TAKEDA GMBH
Reel/Frame 036205/0179 →
Merger Feb 15, 2016
From: TAKEDA GMBH
To: NYCOMED ASSET MANAGEMENT GMBH
Reel/Frame 037820/0324 →
Merger Feb 15, 2016
From: NYCOMED ASSET MANAGEMENT GMBH
To: NYCOMED GERMANY HOLDING GMBH
Reel/Frame 037820/0360 →
Change of Name Feb 15, 2016
From: NYCOMED GERMANY HOLDING GMBH
To: TAKEDA GMBH
Reel/Frame 038020/0258 →
Assignment of Assignor's Interest Jan 11, 2017
From: TAKEDA GMBH
To: ASTRAZENECA AB
Reel/Frame 041328/0362 →
Merger Nov 16, 2018
From: COVIS PHARMA S.A R.L.
To: COVIS PHARMA B.V.
Reel/Frame 047523/0420 →
Assignment of Assignor's Interest Dec 10, 2018
From: ASTRAZENECA AB
To: COVIS PHARMA B.V.
Reel/Frame 047761/0435 →
Security Interest Dec 20, 2018
From: COVIS PHARMA B.V.
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 047834/0926 →
Release of Security Interest Mar 17, 2020
From: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: COVIS PHARMA B.V.
Reel/Frame 052142/0961 →
Business Transfer and Contribution Agreement Dec 16, 2020
From: COVIS PHARMA B.V.
To: COVIS PHARMA GMBH
Reel/Frame 054793/0416 →
Security Interest Feb 22, 2021
From: COVIS PHARMA GMBH
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 055354/0063 →
Notice of Grant of Security Interest in Intellectual Property (First Lien) Jan 4, 2022
From: COVIS PHARMA GMBH
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 058640/0787 →
Release of Security Interest Feb 18, 2022
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: COVIS PHARMA GMBH
Reel/Frame 059043/0226 →
Release of Security Interest Feb 18, 2022
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: COVIS PHARMA B.V.
Reel/Frame 059043/0239 →
Notice of Grant of Security Interest in Intellectual Property (Second Lien) Feb 18, 2022
From: COVIS PHARMA GMBH
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 059232/0514 →
Release of Security Interest Jun 2, 2023
From: BARCLAYS BANK PLC
To: COVIS PHARMA GMBH
Reel/Frame 063841/0208 →